Feb 4, 2025 · Lefty New York City Rep. Alexandria Ocasio-Cortez claimed Monday that Elon Musk, the world's richest man, is stupid during a fiery screed that drew mockery from her critics.

Sep 29, 2023 · Elon Musk, the CEO of X, formerly Twitter, locked horns with Representative Alexandria Ocasio-Cortez (D-NY) this week, after the billionaire accused the politician of being "not that smart."...

8 hours ago · Donors filled the coffers of Democrats who have emerged as prominent critics of President Donald Trump’s action in the first months of his second term – signaling an early surge of enthusiasm ...

15 hours ago · The big haul comes as Ocasio-Cortez and Sen. Bernie Sanders hold rallies across the United States to criticize President Donald Trump, DOGE chief Elon Musk, and others.

Feb 5, 2025 · Rep. Alexandria Ocasio-Cortez, D-N.Y., was swiftly criticized after calling billionaire entrepreneur Elon Musk "one of the most unintelligent billionaires" she has ever encountered, the New York Post reported.

Mar 5, 2025 · Rep. Alexandria Ocasio-Cortez (D-NY) strongly criticized Elon Musk in her latest remarks, calling him a “billionaire con man with a lot of money” during a House Energy and Commerce hearing on...

Feb 4, 2025 · Rep. Alexandria Ocasio-Cortez (D-N.Y.) slammed tech billionaire and Department of Government Efficiency (DOGE) head Elon Musk as “one of the most unintelligent billionaires” she has ever met.

Rep. Alexandria Ocasio-Cortez called Elon Musk “one of the most unintelligent billionaires” she has ever met while condemning his role in President Donald Trump’s administration.

Mar 24, 2025 · Alexandria Ocasio-Cortez teased Elon Musk by writing he was "butthurt" over the enthusiastic response to a rally she headlined. The progressive lawmaker sarcastically urged …

Mar 6, 2025 · Rep. Alexandria Ocasio-Cortez was blunt in her latest criticism of Elon Musk, calling him unfit to influence government affairs. Her vehement remarks came during a House hearing in which she expressed concerns about his involvement in federal agencies and the impact on medical research.